RPTX NASDAQ
Repare Therapeutics Inc.
1W: +19.8%
1M: +22.1%
3M: +45.2%
1Y: +101.5%
3Y: -82.1%
5Y: -92.2%
$2.65
Last traded 2025-12-31 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$177M
-30.5% ▼
5Y CAGR: +11.4%
Total Liabilities
$25M
-39.3% ▼
5Y CAGR: +14.6%
Shareholders Equity
$151M
-28.7% ▼
5Y CAGR: +11.0%
Cash & Investments
$153M
-31.7% ▼
5Y CAGR: +10.0%
Total Debt
$2M
-43.3% ▼
5Y CAGR: +12.7%
Net Debt
-$83M
+23.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $326M | $334M | $160M | $111M | $85M |
| Short-Term Investments | $8M | $7M | $184M | $112M | $68M |
| Cash & ST Investments | $334M | $342M | $344M | $224M | $153M |
| Net Receivables | $6M | $3M | $4M | $15M | $12M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $347M | $351M | $354M | $244M | $171M |
| Property, Plant & Equip. | $9M | $13M | $10M | $8M | $4M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $212K | $0 | $0 | $2M | $0 |
| Other Non-Current Assets | $288K | $586K | $497K | $396K | $1M |
| Total Non-Current Assets | $11M | $17M | $10M | $10M | $5M |
| Total Assets | $357M | $369M | $364M | $254M | $177M |
| — Liabilities — | |||||
| Accounts Payable | $2M | $2M | $461K | $2M | $4M |
| Short-Term Debt | $697K | $2M | $0 | $2M | $0 |
| Deferred Revenue | $2M | $12M | $53M | $10M | $0 |
| Other Current Liabilities | $3M | $14M | $16M | $17M | $166K |
| Total Current Liabilities | $11M | $35M | $79M | $39M | $25M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $3M | $0 | $0 |
| Total Non-Current Liabilities | $59M | $45M | $6M | $3M | $88K |
| Total Liabilities | $70M | $80M | $85M | $42M | $25M |
| — Equity — | |||||
| Common Stock | $384M | $481M | $482M | $483M | $487M |
| Retained Earnings | -$103M | -$210M | -$239M | -$333M | -$418M |
| Accumulated OCI | $0 | $0 | -$428K | $28K | $54K |
| Total Stockholders Equity | $287M | $288M | $280M | $212M | $151M |
| Total Liabilities & Equity | $357M | $369M | $364M | $254M | $177M |
| — Key Metrics — | |||||
| Total Debt | $4M | $7M | $5M | $3M | $2M |
| Net Debt | -$322M | -$327M | -$154M | -$108M | -$83M |
| Total Investments | $8M | $7M | $184M | $115M | $68M |